Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Clinical update on AMG 420, an anti-BCMA BiTE®

  • Broadcast in Science
Pharma Talk Radio

Pharma Talk Radio

Featured Host
×  

Follow This Show

If you liked this show, you should follow Pharma Talk Radio.
h:548881
s:11570681
archived
Play

In this talk, recorded at the 5th annual IO360° Summit, Dr Alex Minella, Amgen, provides a clinical update on AMG 420, an anti-BCMA BiTE®

This talk addresses the:

  • Summary of IND enabling preclinical studies
  • First-in-human trial design
  • First-in-human trial data (safety, efficacy)

Save the date for the 6th annual Immuno-Oncology 360° Summit on February 26-28, 2020 at the Crowne Plaza Times Square in New York City. Learn more at www.io360summit.com

 

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled